INO logo Inovio Pharmaceuticals : INO

INO

Stock Data

$2.06

Change down

$0.07 (3.29%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Inovio Pharmaceuticals Inc is a biotechnology firm dedicated to creating DNA-based medicines for various diseases, including those linked to human papillomavirus (HPV), cancer, and infectious diseases. Their innovative approach involves designing DNA sequences to target specific antigens and using CELLECTRA devices for efficient delivery. With a focus on clinical studies, Inovio is advancing treatments for HPV-related conditions and diseases like Ebola and lassa fever. Founded in 1983 and based in Plymouth Meeting, Pennsylvania, Inovio collaborates with numerous global partners to push the boundaries of DNA medicine.

All Inovio Pharmaceuticals Articles

52 Articles

1 2 3 4

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.